Hence, while similar growing B16 and MC38 tumors show increases in CD8:CD4 T-cell ratio, only the MC38 tumor model shows reduced tumor growth, indicating that quantification of overarching immune subsets does not differentiate between responding and non-responding tumor models. Here, CD4 is linked to neoplasm.